Dose-Dependent Neurochemical and Functional Protection Afforded by Encapsulated CNTF-Producing Cells
Intracerebral delivery of hCNTF has shown considerable neuroprotective potential in animal models of Huntington's disease (HD). The present study describes the relationship between a range of hCNTF doses and the resulting behavioral and neurochemical (striatal ChAT and GAD activity) protection...
Main Author: | Dwaine F. Emerich Ph.D. |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2004-10-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/000000004783983404 |
Similar Items
-
Article Commentary: Encapsulated CNTF-Producing Cells for Huntington's Disease
by: Dwaine F. Emerich
Published: (1999-11-01) -
Neuroprotective Effects of Encapsulated CNTF-Producing Cells in a Rodent Model of Huntington's Disease are Dependent on the Proximity of the Implant to the Lesioned Striatum
by: Dwaine F. Emerich, et al.
Published: (2004-04-01) -
Encapsulated PC 12 Cell Transplants into Hemiparkinsonian Monkeys: A Behavioral, Neuroanatomical, and Neurochemical Analysis
by: Jeffrey H. Kordower, et al.
Published: (1995-03-01) -
Therapeutic Potential of a Polymer-Encapsulated L-Dopa and Dopamine-Producing Cell Line in Rodent and Primate Models of Parkinson's Disease
by: Mark D. Lindner Ph.D., et al.
Published: (1998-03-01) -
Cellular Delivery of Cntf but not Nt-4/5 Prevents Degeneration of Striatal Neurons in a Rodent Model of Huntington's Disease
by: Dwaine F. Emerich, et al.
Published: (1998-03-01)